Form D · Hedge Fund

MPM BioImpact Innovations Equities Master, LP

Boston, MA · CIK 0002028760

Offering snapshot reported Jun 26, 2026 · SEC filing

Reported sold
$105M
Indefinite offering
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 3, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$65.5M$131MJun 28, 2024: $40,000,000.00Jun 28, 2024Jun 27, 2025: $131,071,230.00Jun 27, 2025Jun 26, 2026: $105,210,597.00Jun 26, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$40,000,000 → $105,210,597
  • Reported investors1 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 26, 2026Amendment$105,210,597$65,210,597vs Jun 28, 202410SEC filing
Jun 27, 2025Amendment$131,071,230$91,071,230vs Jun 28, 20247SEC filing
Jun 28, 2024Initial$40,000,000No comparison1SEC filing

Offering details

Securities
Pooled investment fund, Other
Exemptions
3C.7, 06b, 3C
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-517266
The total amount sold and number of investors reflect only sales to residents of the U.S.
Limited Partnership Interests. The General Partner, in its sole and absolute discretion, may accept investments of less than the $1,000,000 minimum.

Source: Form D, filed Jun 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MPM BIOIMPACT INNOVATIONS EQUITIES MASTER, LP

Investment adviser: MPM ASSET MANAGEMENT LLC

Gross asset value
$254M
Beneficial owners
15
ADV minimum commitment
$1M

Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SS&C TECHNOLOGIES, INC BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG BOSTON, Massachusetts, United States
Custodian JEFFERIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian NORTHERN TRUST SECURITIES, INC. CHICAGO, Illinois, United States Related to adviser: No
Prime broker JEFFERIES LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG
PCAOB 185

JEFFERIES LLC
SEC 8-15074

NORTHERN TRUST SECURITIES, INC.
SEC 8-23689

JEFFERIES LLC
CRD 2347 · SEC 8-15074

Filing source

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-6920379274

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christiana Goh Bardon Executive
Kristen Laguerre Executive
N/A Mpm Bio Impact Innovations Equities Gp, Llc Executive
Christopher Wolf Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
399 Boylston Street, Suite 1100
Boston, MA, 02116